-
Mashup Score: 4Heart of Cardio - 3 day(s) ago
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from Heart Failure, Atherosclerosis and Thrombosis to Cardiometabolic Disease, Arrythmia Management and Valvular Heart Disease, on top of other urgent issues for practitioners. This 3-day meeting provides interactive presentations, Q & As, panel discussions and networking opportunities. In addition to the scientific sessions, there will be informative Bonus Presentat
Source: www.heartofcardio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4Heart of Cardio - 4 day(s) ago
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from Heart Failure, Atherosclerosis and Thrombosis to Cardiometabolic Disease, Arrythmia Management and Valvular Heart Disease, on top of other urgent issues for practitioners. This 3-day meeting provides interactive presentations, Q & As, panel discussions and networking opportunities. In addition to the scientific sessions, there will be informative Bonus Presentat
Source: www.heartofcardio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0ACC Conference Wrap-up: Thromboembolic Disease and Antithrombotic Therapy Highlights - 16 day(s) ago
Join us as our faculty review highlights from the conference and discuss optimal management of thromboembolic disease in 2024.
Source: www.medscape.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3ACC Conference Wrap-up: Thromboembolic Disease Highlights - 17 day(s) ago
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify M…
Source: www.youtube.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4ACC Conference Wrap-up: Thromboembolic Disease Highlights - 17 day(s) ago
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify M…
Source: www.youtube.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3ACC Conference Wrap-up: Thromboembolic Disease Highlights - 19 day(s) ago
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify M…
Source: www.youtube.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Home - 23 day(s) ago
Anticoagulant use has been critical for reducing the risk of stroke in patients with atrial fibrillation. However, currently available agents are often underutilized or utilized inappropriately primarily due to safety concerns, leading to suboptimal patient outcomes. Emerging evidence suggests that factor XI is a promising new target for inhibition of pathological thrombosis. Join us in this gameshow format and test your knowledge against your peers about thromboembolic disease and factor XI inhibition!
Source: events.medscapelive.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Home - 26 day(s) ago
Anticoagulant use has been critical for reducing the risk of stroke in patients with atrial fibrillation. However, currently available agents are often underutilized or utilized inappropriately primarily due to safety concerns, leading to suboptimal patient outcomes. Emerging evidence suggests that factor XI is a promising new target for inhibition of pathological thrombosis. Join us in this gameshow format and test your knowledge against your peers about thromboembolic disease and factor XI inhibition!
Source: events.medscapelive.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Who Benefits From Beta Blocker Withdrawal in HFpEF? - 2 month(s) ago
A new study suggested indexed left ventricular systolic volume may predict benefit of beta blocker withdrawal in patients with heart failure with preserved ejection fraction.
Source: www.medscape.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3New Marker of Cardiovascular Risk Discovered in T2D - 2 month(s) ago
The quantity of dysfunctional monocytes appears to indicate poor cardiovascular prognosis in patients with type 2 diabetes, data suggested.
Source: www.medscape.comCategories: General Medicine News, Cardiology News and JournTweet
✍️ Register for the #BackToHeart23 ❤️ Conference. Learn and earn CME credit 🏆 December 8-10, 2023 in Anaheim, California 🌴https://t.co/u96RhgoY2e Meet our Faculty @JavedButler1 #HF #Cardiotwitter #cardiologists #CardioEd #HeartFailure https://t.co/WZUL2kSS65